Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Lange, Catharinaa | Suppa, Pera; b | Frings, Larsc | Brenner, Winfrieda | Spies, Lotharb | Buchert, Ralpha; * | for the Alzheimer’s Disease Neuroimaging Initiative1
Affiliations: [a] Department of Nuclear Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany | [b] jung diagnostics GmbH, Hamburg, Germany | [c] Department of Nuclear Medicine, University of Freiburg, Freiburg, Germany
Correspondence: [*] Correspondence to: Ralph Buchert, Department of Nuclear Medicine, Charité - Universitätsmedizin Berlin, Berlin, 10117,Germany. Tel.: +49 30 450627059; Fax: +49 30 450527912; E-mail: [email protected]
Note: [1] Data used in preparation of this article were obtained from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database (http://adni.loni.usc.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found at: http://adni.loni.usc.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf
Abstract: Background:Positron emission tomography (PET) with the glucose analog F-18-fluorodeoxyglucose (FDG) is widely used in the diagnosis of neurodegenerative diseases. Guidelines recommend voxel-based statistical testing to support visual evaluation of the PET images. However, the performance of voxel-based testing strongly depends on each single preprocessing step involved. Objective:To optimize the processing pipeline of voxel-based testing for the prognosis of dementia in subjects with amnestic mild cognitive impairment (MCI). Methods:The study included 108 ADNI MCI subjects grouped as ‘stable MCI’ (n = 77) or ‘MCI-to-AD converter’ according to their diagnostic trajectory over 3 years. Thirty-two ADNI normals served as controls. Voxel-based testing was performed with the statistical parametric mapping software (SPM8) starting with default settings. The following modifications were added step-by-step: (i) motion correction, (ii) custom-made FDG template, (iii) different reference regions for intensity scaling, and (iv) smoothing was varied between 8 and 18 mm. The t-sum score for hypometabolism within a predefined AD mask was compared between the different settings using receiver operating characteristic (ROC) analysis with respect to differentiation between ‘stable MCI’ and ‘MCI-to-AD converter’. The area (AUC) under the ROC curve was used as performance measure. Results:The default setting provided an AUC of 0.728. The modifications of the processing pipeline improved the AUC up to 0.832 (p = 0.046). Improvement of the AUC was confirmed in an independent validation sample of 241 ADNI MCI subjects (p = 0.048). Conclusion:The prognostic value of voxel-based single subject analysis of brain FDG PET in MCI subjects can be improved considerably by optimizing the processing pipeline.
Keywords: Alzheimer’s Disease Neuroimaging Initiative, F-18-fluorodeoxyglucose, intensity scaling, mild cognitive impairment, positron emission tomography, processing pipeline, prognosis, single subject analysis, statistical parametric mapping, template
DOI: 10.3233/JAD-150814
Journal: Journal of Alzheimer's Disease, vol. 49, no. 4, pp. 945-959, 2016
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]